Affimed N.V. (AFMD): Price and Financial Metrics
AFMD Price/Volume Stats
Current price | $2.72 | 52-week high | $8.95 |
Prev. close | $3.00 | 52-week low | $2.72 |
Day low | $2.72 | Volume | 364,700 |
Day high | $3.03 | Avg. volume | 266,689 |
50-day MA | $3.43 | Dividend yield | N/A |
200-day MA | $4.79 | Market Cap | 43.79M |
AFMD Stock Price Chart Interactive Chart >
Affimed N.V. (AFMD) Company Bio
Affimed NV is a clinical-stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies. The company was founded in 2000 and is based in Heidelberg, Germany.
AFMD Price Returns
1-mo | -21.84% |
3-mo | -35.39% |
6-mo | -35.08% |
1-year | -45.49% |
3-year | -96.14% |
5-year | -88.57% |
YTD | -56.48% |
2023 | -49.60% |
2022 | -77.54% |
2021 | -5.15% |
2020 | 112.41% |
2019 | -11.90% |
Continue Researching AFMD
Want to see what other sources are saying about Affimed NV's financials and stock price? Try the links below:Affimed NV (AFMD) Stock Price | Nasdaq
Affimed NV (AFMD) Stock Quote, History and News - Yahoo Finance
Affimed NV (AFMD) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...